Interestingly, both Usp22 and ATXN7L3, a Usp22 interacting partner required for its enzymatic activity, are shown to be co-recruited with ER to different promoters and regulate the expression levels of downstream targets [27,28,29] in cancer cell lines. This evidence concerns the gene ATXN7L3 and cancer.